Fortune 500: Titans and Disruptors of Industry Google’s AI boss made OpenAI issue code red. Now he wants to solve disease. | Titans and Disruptors
28 snips
Feb 11, 2026 
Demis Hassabis, founder and CEO of DeepMind and Isomorphic, is an AI pioneer behind AlphaGo and AlphaFold. He discusses using AI to cure cancer and speed drug discovery. He explains merging teams to build Gemini and how AI could power universal agents, smart glasses, robotics, and a future of radical abundance.
AI Snips
Chapters
Transcript
Episode notes
AlphaFold's Scientific Breakthrough
- AlphaFold solved a 50-year problem by predicting 3D protein structures from sequences at scale.
- Demis highlights its open database of 200 million structures now used by millions of researchers daily.
Spinning Out Isomorphic For Drug Discovery
- Hassabis explains spinning out Isomorphic to apply AlphaFold-level breakthroughs to chemistry and drug discovery.
- He says Isomorphic runs in-silico search to reduce wet-lab experiments and accelerate programs with pharma partners.
Do Discovery In Silico First
- Do most hypothesis search in silico to save time and cost before validating in wet labs.
- Reserve wet-lab work mainly for validation to streamline drug discovery.